A score to predict short-term risk of COPD exacerbations (SCOPEX)

BACKGROUND: There is no clinically useful score to predict chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to derive this by analyzing data from three existing COPD clinical trials of budesonide/formoterol, formoterol, or placebo in patients with moderate-to-very-severe COPD and...

Descripción completa

Detalles Bibliográficos
Autores principales: Make, Barry J, Eriksson, Göran, Calverley, Peter M, Jenkins, Christine R, Postma, Dirkje S, Peterson, Stefan, Östlund, Ollie, Anzueto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315304/
https://www.ncbi.nlm.nih.gov/pubmed/25670896
http://dx.doi.org/10.2147/COPD.S69589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315304/
https://www.ncbi.nlm.nih.gov/pubmed/25670896
http://dx.doi.org/10.2147/COPD.S69589

Ejemplares similares